Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes - PubMed (original) (raw)
Comparative Study
. 1997 Oct 1;159(7):3288-98.
I D Sizing, P Lawton, P R Bourdon, P D Rennert, G R Majeau, C M Ambrose, C Hession, K Miatkowski, D A Griffiths, A Ngam-ek, W Meier, C D Benjamin, P S Hochman
Affiliations
- PMID: 9317127
Comparative Study
Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes
J L Browning et al. J Immunol. 1997.
Abstract
The lymphotoxin-alpha beta complex (LT alpha beta) is found on the surface of activated lymphocytes and binds to a specific receptor called the LT beta receptor (LT beta R). In the mouse, signaling through this pathway is important for lymph node development and splenic organization, yet the biochemical properties of murine LT alpha and LT beta are essentially unknown. Here we have used soluble receptor-Ig forms of LT beta R and TNF-R55 and mAbs specific for murine LT alpha, LT beta, and LT beta R to characterize the appearance of surface LT alpha beta complexes and LT beta R on several common murine cell lines. Cells that bound LT beta R also bound anti-LT alpha and anti-LT beta mAbs in a FACS analysis. The ability of these reagents to discriminate between surface TNF and LT was verified by analysis of surface TNF-positive, LPS-activated murine RAW 264.7 monocytic cells. Primary mouse leukocytes from spleen, thymus, lymph node, and peritoneum were activated in vitro, and CD4+ and CD8+ T cells as well as B cells expressed surface LT ligand but not the LT beta R. Conversely, elicited peritoneal monocytes/macrophages were surface LT negative yet LT beta R positive. This study shows that on mononuclear cells, surface LT complexes and receptor are expressed similarly in mice and man, and the tools described herein form the foundation for study of the functional roles of the LT system in the mouse.
Similar articles
- Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F, Bourdon PR, Griffiths DA, Lawton P, Zafari M, Sizing ID, Miatkowski K, Ngam-ek A, Benjamin CD, Hession C, Ambrose CM, Meier W, Browning JL. Mackay F, et al. J Immunol. 1997 Oct 1;159(7):3299-310. J Immunol. 1997. PMID: 9317128 - Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
Browning JL, Dougas I, Ngam-ek A, Bourdon PR, Ehrenfels BN, Miatkowski K, Zafari M, Yampaglia AM, Lawton P, Meier W, et al. Browning JL, et al. J Immunol. 1995 Jan 1;154(1):33-46. J Immunol. 1995. PMID: 7995952 - Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
Degli-Esposti MA, Davis-Smith T, Din WS, Smolak PJ, Goodwin RG, Smith CA. Degli-Esposti MA, et al. J Immunol. 1997 Feb 15;158(4):1756-62. J Immunol. 1997. PMID: 9029113 - Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
Warzocha K, Bienvenu J, Coiffier B, Salles G. Warzocha K, et al. Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review. - Lymphotoxin and LIGHT signaling pathways and target genes.
Schneider K, Potter KG, Ware CF. Schneider K, et al. Immunol Rev. 2004 Dec;202:49-66. doi: 10.1111/j.0105-2896.2004.00206.x. Immunol Rev. 2004. PMID: 15546385 Review.
Cited by
- Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.
Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL. Mackay F, et al. J Exp Med. 1999 Dec 6;190(11):1697-710. doi: 10.1084/jem.190.11.1697. J Exp Med. 1999. PMID: 10587360 Free PMC article. - Splenic T zone development is B cell dependent.
Ngo VN, Cornall RJ, Cyster JG. Ngo VN, et al. J Exp Med. 2001 Dec 3;194(11):1649-60. doi: 10.1084/jem.194.11.1649. J Exp Med. 2001. PMID: 11733579 Free PMC article. - The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues.
Wu Q, Wang Y, Wang J, Hedgeman EO, Browning JL, Fu YX. Wu Q, et al. J Exp Med. 1999 Sep 6;190(5):629-38. doi: 10.1084/jem.190.5.629. J Exp Med. 1999. PMID: 10477548 Free PMC article. - Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules.
Tamada K, Chen L. Tamada K, et al. Cancer Immunol Immunother. 2006 Apr;55(4):355-62. doi: 10.1007/s00262-005-0081-y. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187084 Free PMC article. Review. - Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs.
Alcamo E, Hacohen N, Schulte LC, Rennert PD, Hynes RO, Baltimore D. Alcamo E, et al. J Exp Med. 2002 Jan 21;195(2):233-44. doi: 10.1084/jem.20011885. J Exp Med. 2002. PMID: 11805150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials